Trials / Unknown
UnknownNCT04485897
Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring
Can Self-monitoring of the Intraocular Pressure With the Icare HOME Make Hospital-based Diurnal Monitoring Redundant?
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Luzerner Kantonsspital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Glaucoma remains the leading cause of irreversible blindness worldwide. Glaucoma represents a group of diseases that lead to optic nerve damage and corresponding deterioration of the visual field. Elevated intraocular pressure remains the most important risk factor. Interestingly, glaucomatous damage sometimes occurs despite seemingly normal intraocular pressure. Recent studies suggest pressure peaks, which are missed under the current practice of spot intraocular measurements during office hours. In order to detect pressure peaks diurnal measurements are mandatory. Costly in-hospital diurnal measurements are the current standard. The primary study objective is to verify that self-tonometry at home can provide valuable information when looking for pressure peaks in patients with glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | icare HOME device (Icare Oy, Vanda, Finland) | icare HOME device versus hospital based measurements |
Timeline
- Start date
- 2020-11-26
- Primary completion
- 2024-08-01
- Completion
- 2024-08-01
- First posted
- 2020-07-24
- Last updated
- 2024-03-06
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04485897. Inclusion in this directory is not an endorsement.